In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303)

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):319; author reply 319-20. doi: 10.1016/j.ijrobp.2004.01.010.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Follow-Up Studies
  • Humans
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Palladium / therapeutic use*
  • Prospective Studies
  • Prostatic Neoplasms / radiotherapy*
  • Radioisotopes / therapeutic use*
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic
  • Time Factors

Substances

  • Iodine Radioisotopes
  • Radioisotopes
  • Palladium